Boston Scientific Corporation
300 Boston Scientific Way
Marlborough
Massachusetts
01752
United States
Tel: (800) 876-9960
Website: http://www.bostonscientific.com/
1488 articles with Boston Scientific Corporation
-
Boston Scientific Announces Positive Data from the EVOLVE Short DAPT study with the SYNERGY™ Bioabsorbable Polymer Stent
9/26/2019
Study of abbreviated antiplatelet therapy for patients at high risk for bleeding after undergoing percutaneous coronary intervention
-
According to the second biennial 2019 Life Sciences Ideal Employer Report by BioSpace, the top three most important attributes cited by life sciences professionals around the world are the opportunity to do interesting and meaningful work, a competitive salary and health benefits.
-
BioSpace, the leader in life sciences news and careers, today announced that Genentech, Pfizer, Merck, Amgen and Novartis landed in the top five spots of their latest Ideal Employer report.
-
Boston Scientific Announces Scheduled Presentations at Transcatheter Cardiovascular Therapeutics 2019
9/18/2019
Boston Scientific Corporation announced key data that will be presented at the 31st Transcatheter Cardiovascular Therapeutics, the annual scientific symposium of the Cardiovascular Research Foundation, in San Francisco, on September 25 - September 29.
-
Boston Scientific to Participate in the 2019 Wells Fargo Securities Healthcare Conference
8/20/2019
Mike Mahoney, chairman and chief executive officer, and Susie Lisa, vice president, Investor Relations, will participate in a 30-minute question-and-answer session with the host analyst beginning at approximately 8:35 a.m. EDT.
-
Boston Scientific Announces FDA Approval Of ImageReady™ MRI For Vercise Gevia™ Deep Brain Stimulation System
8/19/2019
Boston Scientific Corporation announced the US FDA approval of its ImageReady™ MRI labeling for the Vercise Gevia™ Deep Brain Stimulation System to be used in a full-body magnetic resonance imaging environment.
-
Boston Scientific Closes Acquisition of BTG plc.
8/19/2019
Boston Scientific Corporation announced the completion of its acquisition of BTG plc. pursuant to the previously announced scheme of arrangement.
-
Endologix Announces Exclusive Distributor Agreement with Boston Scientific for the Chinese Market
8/8/2019
The long-term agreement includes distribution rights to Endologix’s current EndoVascular Aneurysm Repair and Endovascular Aneurysm Sealing products, as well as the right of first negotiation for future product offerings by Endologix.
-
BOSTON SCIENTIFIC LAUNCHES TACTRA™ MALLEABLE PENILE PROSTHESIS
7/29/2019
Device provides patients with a durable, natural-feeling implant for the treatment of erectile dysfunction
-
Boston Scientific to Participate in 39th Annual Canaccord Genuity Growth Conference
7/25/2019
Conference on Thursday, August 8, 2019 in Boston.
-
Top 5 Vendors in the Kidney Stones Management Devices Market from 2019 to 2023 | Technavio
7/24/2019
With the aim to improve the quality of care and treatment offered to patients suffering from kidney-related conditions, several public and non-profit organizations are taking initiatives such as expert consultations and free screenings.
-
Boston Scientific Announces Results For Second Quarter 2019
7/24/2019
Boston Scientific Corporation generated sales of $2.631 billion during the second quarter of 2019.
-
Top 5 Vendors in the Transcatheter Embolization and Occlusion Devices Market from 2019 to 2023 | Technavio
7/23/2019
The need for quality patient care has increased owing to the growing aging population and the consequent rise in chronic diseases.
-
Top 5 Vendors in the Nephrostomy Devices Market from 2019 to 2023 | Technavio
7/11/2019
Percutaneous nephrostomy procedures have gained immense popularity over the last few years as they eliminate the need for nephrostomy tube or ureteral stent devices.
-
As the largest center for biotech startups in the U.S., the Boston/Cambridge, Massachusetts area often acts as a marker for the entire industry. Here’s a look at the Massachusetts M&A deals so far.
-
Varian to Expand Interventional Oncology Portfolio with Purchase of Embolic Bead Asset
7/2/2019
Varian announced it has signed an asset purchase agreement to acquire the Boston Scientific portfolio of drug-loadable microsphere and bland embolic bead products for treating arteriovenous malformations and hypervascular tumors.
-
Boston Scientific Announces Conference Call Discussing Second Quarter 2019 Financial Results
7/1/2019
The company will issue a news release announcing financial results for the second quarter on Wednesday, July 24, 2019, prior to the conference call
-
Saluda Medical Raises $75 Million Equity Financing from Boston Scientific and Redmile Group
6/28/2019
Saluda Medical Pty Limited announced that it has secured $75 million in equity financing from Boston Scientific Corporation and Redmile Group LLC to fund the final stages of development through commercialization of its Evoke® ECAP-Controlled, Closed-Loop Spinal Cord Stimulation System for the treatment of chronic intractable pain of the trunk and limbs.
-
H.I.G. BioHealth Partners Completes Sale of Vertiflex to Boston Scientific
6/18/2019
H.I.G. BioHealth Partners recently announced the sale of Vertiflex, Inc. to Boston Scientific for a total equity value of approximately $465 million in cash and additional payments contingent on the Company attaining certain commercial goals.
-
Boston Scientific Closes Acquisition Of Vertiflex, Inc.
6/11/2019
Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Vertiflex, Inc., a privately-held company that developed and commercialized the Superion® Indirect Decompression System, a minimally-invasive device used to improve physical function and reduce pain in patients with lumbar spinal stenosis (LSS) – the narrowing of the spinal canal, which can cause compression of nearby nerves.